FAP and interstitial lung disease: The role of fibroblasts in ILD progression has been well documented and many molecular pathways involved have been reported thus far.[14,15] As previously described, FAP targeting enables physicians to assess loci of ongoing fibrotic remodeling, a hallmark of ILD pathogenesis.